Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome

Pao-Chi Liao (Inventor)

Research output: Patent

Abstract

The invention relates to methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome. By combining a hollow fiber cartridge (HFC) culture system with quantitative proteomics technology, cancer metastasis-related secrectomes can be found. Furthermore, this is the first time to use PARK7 as a biomarker for judging the process of non-small cell lung cancer.
Translated title of the contribution癌症轉移之評估方法及生物標記、抑制癌症轉移之醫藥組成物、及分泌蛋白質體之分析方法
Original languageEnglish
Patent number9194005
Publication statusPublished - 1800

Fingerprint Dive into the research topics of 'Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome'. Together they form a unique fingerprint.

Cite this